Human heart failure is associated with a diminished contractile response to 0-adrenergic agonists. We hypothesized that alterations in the activity of a guanine nucleotide-binding regulatory protein (G protein) might be partially responsible for this abnormality. We therefore measured the activity of G proteins in failing human myocardium utilizing bacterial toxin-catalyzed ADP ribosylation. The activity of a 40,000-mol wt pertussis toxin substrate (aG40) was increased by 36% in failing human hearts when compared with nonfailing controls. In contrast, there was no change in the level of the stimulatory regulatory subunit (G.). The increased activity in aG40 was associated with a 30% decrease in basal as well as 5'-guanylyl imidodiphosphate-stimulated adenylate cyclase activity. These data suggest that increased aG40 activity is a new marker for failing myocardium and may account at least in part for the diminished responsiveness to 01-adrenergic agonists in the failing human heart.
Introduction
Human heart failure is associated with a diminished contractile response to fl-adrenergic agonists (1). Bristow et al. (2, 3) demonstrated downregulation of the f#1-adrenergic receptors and subsensitivity of,-adrenergic responses in failing human hearts. However, another study (4) suggested that human heart failure may be associated with a more global abnormality in the production of the second messenger cyclic AMP by the receptor-adenylate cyclase complex that is independent of adrenergic receptor downregulation.
The hormone receptor-adenylate cyclase system consists of three functionally distinct, membrane-bound proteins: (a) hormone receptors, (b) catalytic adenylate cyclase which synthesizes the intracellular second messenger cyclic AMP, and (c) various guanine nucleotide-binding regulatory proteins which stimulate (Gj) or inhibit (Gi) the catalytic subunit (5) .
Pharmacologic studies of membranes from failing human hearts using fluoride or forskolin, which are selective activators teins, such as Gi, may contribute to the diminished function of the receptor-adenylate cyclase system in heart failure. Gi mediates the action of inhibitory hormones and neurotransmitters on the adenylate cyclase system (5, 7); therefore, altered activity could affect the transduction of transmembrane signals in the failing heart. The G proteins share a common subunit structure: an a subunit which confers identity and a common dimeric, fly subunit (5) . Inasmuch as the fly subunit of Gi appears to mediate inhibition of the G, effects on adenylate cyclase (8, 9) , increased levels ofG; or a related G protein may alter f-adrenergic receptor-adenylate cyclase coupling via changes in concentrations of the fly subunit. The bacterial exotoxins choleragen (10, 1 1) and pertussis toxin (12, 13) catalyze a reaction in which an ADP-ribose is transferred from NAD to specific amino acid acceptors on aG, or aG,, respectively. Utilizing radiolabeled ADP ribose and these selective bacterial toxins, G protein acceptors can be quantified. We measured levels of Gi and G, in normal and failing human hearts using pertussis toxin-or choleragen-dependent ADP ribosylation. We also assayed activity of G. in an in vitro complementation assay using membranes prepared from murine S49 lymphoma cells that are genetically deficient in aG,.
Methods
Procurement ofhuman cardiac tissue. Hearts with severe biventricular failure due to idiopathic dilated cardiomyopathy were obtained from The Johns Hopkins Hospital and Utah Cardiac Transplant programs at the time of cardiectomy for cardiac transplantation. These samples were obtained from nine males and two females with ages from 15 to 58 years (median 38 yr). Patients with ischemic cardiomyopathy were excluded using electrocardiograms, historical criteria, and coronary angiograms. In addition, reversible causes of cardiomyopathy including thyrotoxicosis, connective tissue disease, and hemochromatosis were excluded by appropriate clinical testing and endomyocardial biopsy. All patients were receiving conventional medical therapy that included digoxin, diuretics, and vasodilators. None received intravenous inotropic support or experimental oral inotropes before transplantation; however, one patient was also receiving oral enoximone, a phosphodiesterase inhibitor. Hemodynamic data (mean±SEM) for the patients with cardiac failure were the following: pulmonary wedge pressure 27±2.1 mmHg, cardiac index 1.8±0.1 liter/min * m2, and left ventricular ejection fraction of 13.8±1.1%.
Nonfailing (control) hearts were obtained from organ donors whose hearts were not utilized for transplantation owing to the unavailability of suitable recipients despite multiple attempts to place the heart using the United Network for Organ Sharing (n = 8) or because ofage > 50 yr (n = 3). The received dopamine (2-4 Mug/kg. min) for 2-12 h before organ harvest in order to maintain adequate renal perfusion. Two other subjects received larger doses of dopamine (12 Mg/kg. min for 12 h and 8 ,Mg/kg min for 28 h, respectively) before organ harvest. An echocardiogram used to screen cardiac donors revealed normal left ventricular size and contractility (percent fraction of shortening > 25%) in eight of the nine donors in whom the test was performed. The ninth donor had mild generalized left ventricular hypokinesis, whereas the final two donors had no history of cardiac disease, normal cardiac examination, and a normal chest roentgenogram. Oral and written informed consent for organ donation for transplantation or research purposes was obtained before cardiectomy (1) . The excised hearts were immediately placed in ice-cold physiologic buffer and transported to the laboratory. The time between cross-clamp and tissue homogenization was 30 min. For one heart which was procured off-site, the cold ischemic time was < 2 h.
Cardiac membrane preparation. Approximately 3-5 g of the left ventricular free wall was excised and prepared as previously described (1, 14) . The epicardium and endocardium were rapidly stripped and the tissue was minced in 5 vol of ice-cold buffer containing 5 mM Tris-Cl, pH 7.4, 250 mM sucrose, and 1 mM EGTA. The tissue was then homogenized with a Polytron (Brinkman Instruments Co., Westbury, NY) at full speed for < 5 s and centrifuged ( 1,100 g for 20 min) at 4VC. The supernatant from this first centrifugation fraction was used for creatine kinase assays (1). The pellet was resuspended in the same buffer using a Potter-Elvejehm homogenizer and the pellet was washed three times. The final membrane fraction was filtered through sterile gauze and stored at -70'C. Storage for 6 mo had no effect on the levels of aG4o or CaG42-52 as assayed by bacterial toxin-dependent ADP ribosylation. Protein was measured (15) using bovine serum albumin as standard.
Another 5-g aliquot of left ventricular free wall was placed in icecold 10 mM Tris-Cl-l mM EGTA buffer (pH 8.0), minced, and homogenized as previously described (3). This "crude membrane" fraction was washed and stored at -70°C for use in receptor binding studies.
Pertussis toxin ADP ribosylation. G protein substrates of pertussis toxin were assayed using pertussis toxin-catalyzed incorporation of
[32P]ADP-ribose from [32P]NAD (12, 13) . Membranes (50 Mg) were centrifuged (15,000 g for 5 min) and resuspended in 100 Mul of incubation buffer containing 100 mM Tris-Cl, pH 8, 6 mM MgCI2, 2 mM GTP, 10 mM thymidine, 2.5 mM ATP, 10 mM isoniazid, and 10;tM [32P]NAD (10 Ci/mmol). Pertussis toxin was activated by dialyzing with 10 mM Tris-CI, pH 8.0, for 1 h at 4°C and incubating in 100 mM dithiothreitol for 30 min at room temperature. After addition of activated pertussis toxin (2.5 Mg), the membrane preparations were incubated for 90 min at 30°C. The ADP ribosylation reactions were stopped by centrifugation at 15,000 g for 5 min and washing the pellet with ice-cold buffer containing 50 mM Tris-Cl, pH 8, 5% sucrose, 6 mM MgCI2, 1 mM EDTA, and 1 mM dithiothreitol. Human erythrocyte membranes (16) (20 Ci/mmol) . Cholera toxin was activated by incubating in 100 mM dithiothreitol for 30 min at 30°C.
After the addition of 5 Mug of activated cholera toxin, the membrane preparations were incubated for 90 min at 30°C. Reactions were stopped by centrifugation at 15,000 g for 5 min and washing the pellet with ice-cold buffer containing 50 mM Tris-Cl, pH 8, 5% sucrose, 6 mM MgCI2, 1 mM EDTA, and 1 mM dithiothreitol. Membranes from human erythrocytes were radiolabeled concurrently in these experiments.
Protein electrophoresis and measurement ofautoradiographic densities. The membrane pellets were resuspended in 50 Ml of a solution containing 62.5 mM Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, and 5% fl-mercaptoethanol and loaded into the wells ofa 7.5% SDS-polyacrylamide gel for electrophoresis ( 17) . Gels were dried on cellophane and exposed Kodak XAR-5 film with an intensifying screen at -70'C for 4 d. The signal intensity of the appropriate bands on the autoradiogram was analyzed using a two-dimensional densitometer (Loates, Westminister, MD) (18) . It was technically difficult to apply the same amount of protein in each lane of the gels; therefore, these autoradiographic measurements were corrected for total protein in each lane by utilizing Coomassie Blue-stained proteins on the same gels. The amount of protein in four randomly selected Coomassie Blue-stained protein bands with approximate molecular weights of 126,000, 57,000, 52,000, and 38,000 was quantified using two-dimensional transmission densitometry. These bands were chosen because there was minimal surrounding Coomassie Blue-stained material and because the concentrations of these proteins was the same in cardiac membranes from control and failing hearts (data not shown). The interlane density ratios of these bands allowed correction for total protein in each lane. Because the density of the 40,000-mol wt band on autoradiographics varied in different experiments owing to variations in the film exposure time and specific activity ofthe [32P]NAD, we standardized autoradiographic densities obtained from separate experiments by including membranes from at least three nonfailing hearts in each experiment. The levels of the ADP-ribosylated proteins in membranes from failing hearts was then calculated as a percentage ofthe mean ofthe nonfailing controls. This method ofcomparing G protein levels in the same tissue from different individuals has been used extensively by others (19) (20) (21) . Each membrane preparation was assayed in two or more separate experiments and the values reported are the average ofthese replicates. Statistical comparisons were performed using a nonpaired t test (22) .
Reconstitution assay ofG, activity. We also assayed G, by measuring the ability of G proteins extracted from cardiac membranes in detergent to complement the genetic G, deficiency of murine S49 cycmembranes (23) in vitro utilizing a modification of previously described techniques (24, 25) . S49 cyc-mouse lymphoma cells were propagated in Dulbecco's modified Eagle's medium containing 10% heat-inactivated horse serum (26) . Plasma membranes were prepared by the method of Johnson and Bourne (27) utilizing a nitrogen disruption apparatus (Parr Instrument Co., Moline, IL) to disrupt the cells by nitrogen cavitation and sucrose density-gradient separation to purify the membranes.
The reconstitution assay was a modification of that described by Levine et al. (28) . Cardiac membranes were incubated at 380C for 30 min and pellets were then prepared by centrifugation at 15,000 g for 5 min at room temperature. The pellets were solubilized in buffer (2.5 mg/ml) containing 10 mM Tris-Cl (pH 7.5), 10 mM MgCl2, 0.1 mM EDTA, 1 mM dithiothreitol, and 0.2% (wt/vol) Lubrol PX for 60 min at room temperature. After centrifugation at 15,000 g for 15 min at room temperature, the supernatant (membrane extract) was removed and utilized immediately for assay of G protein activity. Cyc-membranes (40 Mg) and cardiac membrane extract (15 Ml) were incubated for 20 min at 30°C in buffer containing 50 mM Hepes, pH 7.4, 10 mM MgCl2, 0.3 mM KCI, 20MM cyclic AMP, 0.1 mM dithiothreitol, 5 mM creatine phosphate, 2.8 U creatine phosphokinase, and the appropriate agonists in a total volume of 90 M. After the 20-min incubation, 10 MA of buffer containing [a-32P]ATP (0.1 Ci/mmol) was added and the incubation was continued for 40 min at 30°C. The reaction was terminated by adding 100 Ml of cold 50 mM Hepes buffer, pH 7.5, containing 2 mM ATP, 0.5 mM [3H]cyclic AMP (0.8 Ci/mol), and 2% SDS and heating the mixture to 95°C for 3 min. The [32P]cyclic AMP synthesized during the incubation was fractionated using Dowex-alumina chromatography (Dow Chemical Co., Midland, MI) (29) . Cardiac membrane extracts demonstrated a small amount of adenylate cyclase activity in response to stimulators. Therefore this activity was subtracted from the activity of combined cardiac extract and cycmembranes to obtain the increment due to the addition of G, The 190 intrinsic adenylate cyclase activity in the cyC membranes in the presence of isoproterenol plus 5'-guanylyl imidodiphosphate (Gpp(NH)p)' or forskolin was negligible. Preliminary studies demonstrated that the amount of cyclic AMP formed in the assay reaction tube was dependent upon the amount ofadded extract and this relationship was linear over a range of 5-30 ,ul ofextract. Therefore, all assays utilized 15 ,d of extract. The total amount ofprotein and detergent in these preliminary studies was kept constant by supplementing the reaction mixtures with cardiac membrane extracts which had been heated to 90'C for 10 min to inactivate the G proteins. As the data reported in the present study was acquired utilizing cyct membranes harvested at the same time, values are reported as the mean picomoles cyclic AMP produced ±SEM for duplicate determinations. Cyclic AMP production was linear over the 40-min incubation period.
Adenylate cyclase assay. Adenylate cyclase activity was measured as previously described (1, 14) . Briefly, cardiac membranes were incu- Ci/mol), and 2% SDS (100 Ml) and heating the mixture to 95°C for 3 min. The [32P]cyclic AMP synthesized during the incubation was fractionated using Dowex-alumina chromatography (29) . Recovery of cyclic AMP was 70-85%.
fl-Adrenergic receptor binding. ,B-Receptor density was measured by ['25I]iodocyanopindolol (ICYP) binding, as previously described (3, 6) . Briefly, 40-150 Mg/ml of crude membranes was incubated at 30°C for 2 h with increasing doses ofICYP (3-150 pM). Specific binding was defined as that displaced by I MM L-propranolol, and the binding parameters B,,,, and KD were determined by nonlinear least-squared fitting as previously described (3).
Creatine kinase. Creatine kinase was measured in the 1,100 g supernatants by a spectrophotometric technique used previously (1 (Fig. 1) . Additionally, when membranes treated for 90 min were washed and then reincubated with fresh [32P]NAD and pertussis toxin, more radiolabel was not incorporated into aG40 (Fig. 1) (Fig. 8) . Furthermore, levels ofthe 51,000-mol wt peptide were similar in membranes from failing (117.3±6.0%, mean±SEM, n = 6) and nonfailing hearts (99.6±1 1.0%, n = 6). These results were confirmed by the fact that membrane extract from failing hearts did not differ from nonfailing hearts in its ability to reconstitute adenylate cyclase activity in cyC membranes in the presence of the activators isoproterenol plus Gpp(NH)p with or without the catalytic unit agonist forskolin (Fig. 8) .
Adenylate cyclase assay. To determine the functional significance of alterations in G protein levels, we measured ade- also reduced significantly (P < 0.05) in preparations derived from failing hearts. Net stimulation by Gpp(NH)p (stimulation with agonist minus basal activity) was also reduced by 28% (P < 0.05) in preparations derived from failing heart. Furthermore, forskolin-stimulated adenylate cyclase activity was lower in membranes from failing hearts in the presence of low concentrations (endogenous) ofguanyl nucleotides (Table  II) when compared with nonfailing controls. In contrast, stimulation by 10 mM fluoride was not significantly different in the two groups, in that the net stimulation in the failing group was 93% of the stimulation encountered in preparations derived from nonfailing hearts. In a separate experiment, membranes from failing and nonfailing hearts were incubated for 90 min at 37°C in the presence of either activated or heart-inactivated pertussis toxin under the conditions described for the ADP ribosylation reaction. Basal adenylate cyclase activity, as well as that stimulated by forskolin and Gpp(NH)p, was significantly lower in the membranes from failing heart than in membranes from nonfailing controls (Table III) . By contrast, basal and activated adenylate cyclase activity was the same in membranes from failing and nonfailing human heart after pertussis toxin treatment. The reduction in basal adenylate cyclase during the incubation results from heat lability of the catalytic subunit of adenylate cyclase; however, a 90-min labeling period was required for maximal ADP ribosylation (Fig. 1 Two-dimensional densitometric measurements of the autoradiographic bands is given in arbitrary density units (OD X area).
f3-Adrenergic receptor, creatine kinase measurements. As shown in Table IV , maximum ICYP binding was markedly reduced in crude membrane fractions derived from failing human left ventricles; the Bm. value was decreased by 53% when compared with nonfailing preparations. In contrast, ICYP-receptor dissociation constants were not significantly different in failing and nonfailing heart preparations. Similarly, creatine kinase enzymatic activity, a marker of viable myocardium, was not significantly different in soluble fractions derived from failing and nonfailing ventricles (Table IV) . 
Discussion
We have demonstrated that the levels of pertussis toxin substrate aG4o is increased by 36% in failing human hearts when compared with nonfailing control hearts. By contrast, aG, activity as measured by either cholera toxin-dependent ADP ribosylation or in vitro complementation assay was unchanged in the failing human heart. This alteration in aG40 protein substrate was associated with a 30% decrease in basal and Gpp(NH)p-stimulated adenylate cyclase activity. We found two cholera toxin substrates in particulate fractions of human heart. The presence of two cholera toxin substrates (45,000 and 52,000 mol wt) in cardiac and other tissue has been reported previously (10) , and it has been shown that the two species are encdded by distinct mRNAs which arise from a single gene by internal alternative RNA splicing (31) . However, the finding oftwo distinct radiolabeled peptide substrates for pertussis toxin-catalyzed ADP ribosylation in human cardiac membranes has not been previously demonstrated. The 40,000-mol wt radiolabeled peptide putatively represents a G protein in that it is a substrate for ADP ribosylation by pertussis toxin (12, 13) and comigrates with the 40,000-mol wt pertussis toxin substrate of human erythrocytes. However, we cannot definitively identify this 40,000-mol wt pertussis toxin substrate in heart as aGi because a closely related pertussis toxin substrate of 39,000 mol wt (aG39) has been demonstrated in several tissues including heart (32, 33) . Because the physiologic role of aG39 is unknown, there are no functional assays available to assess its activity in native membranes. The 40,000-mol wt peptide that we have described presumably represents aGi as it comigrates with the pertussis toxin substrate in human erythrocytes which have not been shown to contain a 39,000-mol wt substrate. Furthermore, in most intact membranes only a 40,000-mol wt ADP ribosylated than the 39,000-mol peptide (34) . However, more definitive assessments will be necessary. Immunoquantitative studies of aG1 and aG39 are in progress in our laboratory; however, these may be difficult as at least three distinct species of aGi (35) have recently been identified and antisera must be characterized as being selective for each of these three aGi species. Therefore, because the 40,000-mol wt peptide has not been definitively identified, we have chosen to refer to it as aG40.
It is unlikely that the 40,000-mol wt peptide is a proteolytic fragment of the 42,000-mol wt peptide since one-dimensional proteolytic mapping of the 42,000-and 40,000-mol wt peptides revealed different patterns. Furthermore, 32P incorporation into the 42,000-mol wt peptide by pertussis toxin was not different in failing and nonfailing human hearts, in contrast to the changes seen in the 40,000-mol wt peptide. Malbon et al. (36) have reported a second substrate for pertussis toxin-catalyzed ADP ribosylation in rabbit heart; however, this peptide was smaller (40,000 mol wt) than Gi (41,000 mol wt). This apparent discrepancy between his and our data may have resulted from differing electrophoresis conditions. When we used a 10% rather than a 7.5% polyacrylamide gel, a single 40,000-mol wt radiolabeled peptide band was observed (unpublished results). Human cardiac tissues to ,3-adrenergic agents. However, recent studies (8, 9) suggest that the free ,By subunit ofG proteins rather than aG1 mediates inhibition of adenylate cyclase. Therefore, the concentration of ly may be as important in the overall physiologic response as the activity of aG. Finally, the recent demonstration that the 40,000-mol wt subunit of G protein designated GK (37) directly modulates atrial potassium channels suggests that increased cardiac aG4o may alter cardiac function via mechanisms not directly affecting adenylate cyclase. A second limitation of ADP ribosylation is that it does not allow us to determine whether the absolute amount ofaG4o is increased or whether some aG40 in normal heart membrane has been structurally or functionally altered so it is not ADP ribosylated by pertussis toxin. Electrophoretic migration of the radiolabeled aG4o was identical in all samples, implying structural similarity; however, electrophoretic mobility is an insensitive measure of minor alterations in peptide structure. Therefore, further investigations will be needed to determine the functional significance and mechanism responsible for our study results. The increase in aG40 in failing human heart was associated with a decrease in basal and Gpp(NH)p-stimulated adenylate cyclase activity but not in fluoride-stimulated activity. Fluoride appears to activate adenylate cyclase by enhancing the (40) . Our data from the cholera toxin-catalyzed ADP ribosylation and fluoride stimulation of adenylate cyclase indicate that aGs is not structurally or functionally compromised in the failing human heart.
By contrast, the reduced basal adenylate cyclase activity, the reduced maximal response to Gpp(NH)p, and the enhanced inhibitory effect of Gpp(NH)p and low concentrations of GTP on forskolin-stimulated adenylate cyclase activity in the failing heart, coupled with normal functioning of GS, suggest that there is increased functional activity of the inhibitory G protein pathway in the failing heart. Unlike fluoride, Gpp(NH)p reversibly dissociates G proteins into its subunits (41) , and Gpp(NH)p-mediated activation of adenylate cyclase can be reversed by GTP, # agonists, or adenosine, presumably by reassociation of aG, with free fly subunits. Furthermore, both Gs and G1 can exist in an active undissociated Gpp(NH)p-bound form (38) . Therefore, activation of G proteins by Gpp(NH)p allows for expression of both the stimulatory and inhibitory G pathways and the amount of adenylate cyclase stimulation is due to a net effect of both aG1 and aG, activity. Thus, the decrease in basal adenylate cyclase activity 
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Assay conditions were identical to those described in Methods.
Values given as mean±SEM. and the diminished response to Gpp(NH)p in preparations derived from failing heart can be interpreted as representing an increase in inhibitory G regulatory activity. That forskolinmediated stimulation of adenylate cyclase activity can be inhibited by guanyl nucleotides has been demonstrated in the human heart (6) as well as in other systems (42) . Furthermore, recent studies (43) have suggested that this effect is mediated via GQ. Therefore, the present results imply that the function of the inhibitory pathway is increased in failing myocardium. If the inhibitory G regulatory activity is increased, we would expect an alteration in the activity of the muscarinic receptor. In fact, recent studies have demonstrated tighter coupling of muscarinic receptors to adenylate cyclase inhibition in human heart membranes obtained from patients with idiopathic dilated cardiomyopathy when compared with nonfailing controls (44). Finally, the fact that both the decrease in basal adenylate cyclase activity and the enhanced inhibition of forskolin-stimulated activity by Gpp(NH)p disappears after inactivation of G1 by pertussis toxin, implies the presence ofan increase in inhibitory G regulatory activity in failing human hearts.
Several previous studies (1, 3, 6) have described a reduction in a-receptor density in the failing human heart that is similar to the reduction found in the current investigation. In this and previous studies, the fluoride-stimulated response ofadenylate (48) . Choleragen and pertussis toxin, the causative toxins for chol-era and whooping cough, respectively, exert their cellular effects by altering G protein function in the gut or respiratory tract (49) . Additionally, pseudohypoparathyroidism type Ia, a multihormone resistance syndrome, results from a heritable generalized deficiency of aG, (19) (20) (21) .
Our studies were performed at the terminal stage of heart failure. Therefore, we cannot ascertain whether increased levels of aG40 are an acquired defect of pathophysiologic significance or a nonspecific response to myocardial failure or pharmacologic therapy. However, the evidence for increased aG40 activity in the failing human heart implies that stimulation of cardiac muscle contraction by receptor pathways coupled to G, may be under tonic inhibition, or that inotropic stimulation by f3-adrenergic mechanisms might be constrained not only by the reduction in #-receptor density that occurs in the failing heart but also by the increased degree of inhibition by receptor traffic coupled through aG40. Thus, increased aG40 activity is a new marker for failing myocardium and has implications for further understanding of the biochemistry of heart failure.
